Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/30/2018 |
| Start Date: | July 2013 |
| End Date: | July 2019 |
| Contact: | Jesse McCann, B.S. |
| Email: | jpmccann@pennmedicine.upenn.edu |
| Phone: | 215-746-3327 |
The purpose of this study is to determine whether 60-minute sessions of prolonged exposure
(PE) are as effective as the standard 90-minute session for treating posttraumatic stress
disorder (PTSD). Participants will include patients ages 18 or older with a current diagnosis
of PTSD who are seeking treatment in our clinic. Patients who have current substance
dependence, psychosis, and suicidal ideation with intent and plan may not be suitable for
receiving PE and may be offered another treatment or referred to a different treatment
center. Participants will be randomized to receive either the 90- minute or 60-minute PE
session. A blind evaluator will assess for pre-treatment, post-treatment, and follow-up
levels of symptom severity using the PTSD Symptoms Scale Interview (PSS-I). Participants will
attend weekly treatment sessions with any of our faculty members and will complete
self-report measures at every session (see below).
(PE) are as effective as the standard 90-minute session for treating posttraumatic stress
disorder (PTSD). Participants will include patients ages 18 or older with a current diagnosis
of PTSD who are seeking treatment in our clinic. Patients who have current substance
dependence, psychosis, and suicidal ideation with intent and plan may not be suitable for
receiving PE and may be offered another treatment or referred to a different treatment
center. Participants will be randomized to receive either the 90- minute or 60-minute PE
session. A blind evaluator will assess for pre-treatment, post-treatment, and follow-up
levels of symptom severity using the PTSD Symptoms Scale Interview (PSS-I). Participants will
attend weekly treatment sessions with any of our faculty members and will complete
self-report measures at every session (see below).
Inclusion Criteria:
- Primary diagnosis of PTSD
- Recommended by therapist to receive Prolonged Exposure therapy
Exclusion Criteria:
- Current substance dependence, psychosis, suicidal ideation with intent and plan, or
other psychiatric problems warranting immediate clinical attention or would interfere
with Prolonged Exposure therapy
We found this trial at
1
site
Philadelphia, Pennsylvania 19106
Principal Investigator: Edna B. Foa, Ph.D.
Phone: 215-746-3327
Click here to add this to my saved trials
